---
category: news
title: "Tempus Announces Companion Diagnostic Collaboration With A2 Biotherapeutics"
excerpt: "Tempus, a leader in artificial intelligence and precision medicine, today announced a strategic collaboration to develop a companion diagnostic (CDx) test with A2 Biotherapeutics for its new therapy targeting patients with Loss of Heterozygosity (LOH)."
publishedDateTime: 2021-01-13T19:20:00Z
originalUrl: "https://apnews.com/press-release/business-wire/technology-medical-technology-tumors-diagnosis-and-treatment-health-bbd2bb37dd7b452b9f4f809dc702faf9"
webUrl: "https://apnews.com/press-release/business-wire/technology-medical-technology-tumors-diagnosis-and-treatment-health-bbd2bb37dd7b452b9f4f809dc702faf9"
type: article
quality: 22
heat: 22
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "HiberCell and Biodesix Initiate Broad Collaboration for Companion Diagnostic Discovery, Development and Commercialization"
    excerpt: "Initial program to focus on development of a companion diagnostic for HiberCellâ€™s novel immunotherapy, Imprime PGG, to aid in patient selection across multiple oncology programs Biodesix, Inc. (Nasdaq: BDSX) today announced an agreement with HiberCell,"
    publishedDateTime: 2021-01-13T12:25:00Z
    webUrl: "https://www.morningstar.com/news/business-wire/20210113005304/hibercell-and-biodesix-initiate-broad-collaboration-for-companion-diagnostic-discovery-development-and-commercialization"
    type: article
    provider:
      name: Morningstar, Inc.
      domain: morningstar.com
    quality: 0
  - title: "HiberCell and Biodesix Initiate Broad Collaboration for Companion Diagnostic Discovery, Development and Commercialization"
    excerpt: "Biodesix leverages multiple technologies with its proprietary artificial intelligence platform to discover, develop and commercialize diagnostic solutions for unmet clinical needs"
    publishedDateTime: 2021-01-14T06:43:00Z
    webUrl: "https://apnews.com/press-release/business-wire/technology-business-corporate-news-biotechnology-drug-trials-e1214f6c93aa4ac28fabaf54b6dd37be"
    type: article
    provider:
      name: Associated Press
      domain: apnews.com
    quality: 0

secured: "lBkHib5odStU13W2TOjmNWIai9nGFLGnvP8NQw6gRC3XjY32hRiK2FLWDcuSfk0Jqf0jjwuLJegQOzExy5SirwKUhHvuEYMlYiiy9DuOEJbvduylu0I68JbuIAXVV8QxEI6kwAxI7pR9eVJ5/eprhUjovMcWaTTjKK7AuNgMiYGw7U3FPBPfDiRN6oqggsw486a3uCVxNJIVwSbg9anj7kl78NgidiCurPahYBC3t7IE1YSh5fbMvX4VNMwu79uRioZv3JnIQl3E+x8RGx2pOCc1kvT9RLZBZGcWssqpvlXgOl84Y0oIbvkVxM/4sUnTMojSAbNIasIg65g7ewmZNqxMLWVRUghOlPG0qxev6vs=;YROJdMQ2XBqiJsbgzYQurw=="
---

